Mometasone furoate
Pronasal, 50 micrograms/dose, nasal spray, suspension contains mometasone furoate, which belongs to a group of medicines called corticosteroids. Mometasone furoate should not be confused with anabolic steroids in tablet or injection form, which are misused by some athletes. Mometasone furoate administered intranasally relieves the symptoms of nasal mucosa inflammation (swelling and irritation of the nasal mucosa), sneezing, itching, and a stuffy nose, and reduces the amount of nasal discharge.
Hay fever and year-round allergic rhinitis
Pronasal is used to treat the symptoms of hay fever (also known as seasonal allergic rhinitis) and year-round allergic rhinitis in adults and children aged 3 and over.
Hay fever, which occurs at certain times of the year, is an allergic reaction caused by inhaling pollen from trees, grasses, and other plants, as well as mold and fungus spores. Year-round allergic rhinitis occurs throughout the year, and symptoms may be caused by increased sensitivity to various factors, including house dust, animal dander (or shed skin), feathers, and some foods. Pronasal reduces swelling and irritation of the nasal mucosa, thereby relieving symptoms of sneezing, itching, stuffy nose, and reducing the amount of nasal discharge caused by hay fever or year-round allergic rhinitis.
Nasal polyps
Pronasal is used to treat nasal polyps in adults over 18 years of age.
Nasal polyps are small growths on the nasal mucosa, usually occurring in both nostrils.
Pronasal reduces inflammation in the nose, causing a gradual reduction in nasal polyps, thereby reducing the feeling of a stuffy nose, which can make breathing difficult.
Before starting to use Pronasal, discuss it with your doctor or pharmacist.
While using Pronasal, discuss it with your doctor
If corticosteroids in the form of a nasal spray are taken in high doses for a long time, side effects may occur due to the absorption of the medicine into the body.
If itching or eye irritation occurs, the doctor may prescribe other treatment with Pronasal.
If the patient experiences blurred vision or other vision disturbances, they should contact their doctor.
If corticosteroids in the form of a nasal spray are taken in high doses for a long time, they may cause certain side effects, such as slowing down the growth rate in children.
It is recommended to regularly monitor the growth of children receiving long-term corticosteroid treatment, and if any changes are noticed, inform the doctor.
Tell your doctor or pharmacist about all the medicines you are taking, or have recently taken, including those obtained without a prescription.
If you are being treated for allergies with other corticosteroids orally or by injection, your doctor may advise you to stop taking them when you start using Pronasal. In some patients, after stopping oral or injectable corticosteroids, side effects such as joint or muscle pain, weakness, and depression may occur. Other allergic symptoms, such as itching, tearing, or red and itchy skin patches, may also appear. Contact your doctor if you experience any of these symptoms.
Some medicines may enhance the effect of Pronasal. Your doctor may then closely monitor your condition when taking such medicines (including certain HIV medicines: ritonavir, cobicistat).
There is no data or only limited data on the use of Pronasal in pregnant women.
It is not known whether mometasone furoate passes into breast milk.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, consult your doctor or pharmacist before using this medicine.
There is no data on the effect of Pronasal on the ability to drive and use machines.
This medicine contains 20 micrograms of benzalkonium chloride in each dose (0.1 ml), which may cause irritation or swelling inside the nose, especially if used for a long time.
Always use this medicine exactly as your doctor or pharmacist has told you. If you are not sure, consult your doctor or pharmacist. Do not use the nasal spray in larger doses, more frequently, or for longer than your doctor has prescribed.
In some patients, relief of symptoms occurs within 12 hours of administration of the first dose of Pronasal, but the full benefits of treatment may not be observed within the first two days of treatment. Therefore, it is necessary to continue regular use to achieve the full benefits of treatment.
If the patient has severe symptoms of hay fever, the doctor may recommend starting to use Pronasal a few days before the start of the pollen season. This will help prevent the symptoms of hay fever from occurring. At the end of the pollen season, an improvement may occur, and treatment may no longer be necessary.
If after 5 to 6 weeks of using the medicine twice a day, there is no improvement, the patient should consult their doctor, who may recommend changing Pronasal to another medicine.
Pronasal nasal spray has a protective cap that protects the tip of the dispenser and prevents it from getting dirty. Remember to remove it before use and put it back on after use.
Before the first use, check the operation of the spray by pressing the bottle 10 times until a fine mist is obtained:
Figure 1
If the spray has not been used for 14 days or more, check its operation by pressing the bottle 2 times until a fine mist is obtained.
If you use two doses of the nasal spray in each nostril once a day to treat hay fever, year-round allergic rhinitis, and nasal polyps, the medicine will last for 15 days of treatment (for bottles containing 60 measured doses), 30 days (for bottles containing 120 measured doses), or 35 days of treatment (for bottles containing 140 measured doses).
Protective cap Tip of the dispenser Bottle | Figure 2![]() |
Figure 3
Figure 4
Figure 5
After use, carefully wipe the tip of the dispenser with a clean tissue or cloth and put the protective cap back on to prevent dust from entering.
Protective cap | Figure 6![]() | Tip of the dispenser | Figure 7![]() |
Protective cap | Figure 8![]() | Tip of the dispenser | Figure 9![]() |
Central hole Tip of the dispenser Spraying system | Figure 10![]() | Figure 11![]() |
Figure 12
Consult your doctor if you have accidentally used a higher dose of the medicine than recommended.
If corticosteroids are used for a long time or in high doses, they may have an adverse effect on the patient's hormones. In children, they may affect growth and development.
If you forget to use the nasal spray at the usual time, use it as soon as you remember, then continue treatment at the usual time. Do not use a double dose to make up for the missed dose.
In some patients, improvement occurs within 12 hours of administration of the first dose of Pronasal, although the full benefits of treatment may not be observed until after 2 days of treatment. It is very important to use the nasal spray regularly. Do not stop treatment, even if you feel better, unless your doctor has explicitly advised you to.
If you have any further doubts about using the medicine, consult your doctor or pharmacist.
Like all medicines, Pronasal can cause side effects, although not everybody gets them.
After using the medicine, immediate allergic reactions (hypersensitivity) may occur. These reactions can be severe. Stop using Pronasal and seek medical help immediately if you experience symptoms such as:
If corticosteroids in the form of a nasal spray are taken in high doses for a long time, side effects may occur due to the absorption of the medicine into the body.
Other side effects
Most people using Pronasal do not report any side effects after using the nasal spray. However, some people using Pronasal or another corticosteroid nasal spray have reported the following side effects:
Common side effects (may affect up to 1 in 10 people):
Frequency not known (frequency cannot be estimated from the available data):
It is expected that the frequency and type of side effects in children will be the same as in adults.
Long-term use of high doses of corticosteroids in a nasal spray may cause side effects such as slowing down the growth rate in children. Regular monitoring of growth in children receiving long-term corticosteroid treatment is recommended. If any changes are noticed, inform the doctor.
If you experience any side effects, including those not listed in the leaflet, tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of the medicine.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the bottle and carton after: {Expiry date (EXP):} or {EXP:}. The expiry date refers to the last day of the month.
Do not store above 25°C. Do not freeze.
The nasal spray should be used within 8 weeks of first use.
Medicines should not be disposed of via wastewater. Ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Pronasal is a nasal spray, suspension.
Each bottle contains 60 or 140 doses of the medicine.
Bottles containing 60 doses are available in single packs.
Bottles containing 140 doses are available in packs of 1, 2, or 3 nasal sprays.
Not all pack sizes may be marketed.
Teva Pharmaceuticals Polska Sp. z o.o.
ul. Emilii Plater 53; 00-113 Warsaw
phone: (22) 345 93 00
Teva Czech Industries s.r.o.
Ostravská 29, č.p. 305, 747 70 Opava-Komárov
Czech Republic
Merckle GmbH (manufacturer where batch release occurs - only for Germany)
Ludwig-Merckle-Str.3
89143 Blaubeuren
Germany
Austria:
Mometason Ratiopharm 50 µg/Dosis Nasenspray
Belgium:
Mometasone Teva 50 microgram per verstuiving, neusspray, suspensie
Denmark:
Mometasonfuroat Teva
Finland:
Momesonex 50 mikrog/annos nenäsumute, suspensie
France:
MOMETASONE TEVA 50 microgrammes/dose, suspension pour pulvérisation nasale.
Spain: Mometasona Teva 50 microgramos suspensión para pulverización nasal EFG
Netherlands:
Mometasonfuroaat Teva 50 microgram/verstuiving, neusspray, suspensie
Lithuania:
Mometasone Teva 50 mikrogramų/dozėje nosies purškalas (suspensija)
Germany:
Mometasonfuroat AbZ 50 Mikrogramm/Sprühstoß Nasenspray, Suspension
Poland:
Pronasal
Portugal: Mometasona Teva
Sweden:
Mometasone Teva 50 mikrogram/dos nässpray, suspension
Hungary:
Nasotasone 50 mcg szuszpenziós adagolt orrspray
Italy:
Mometasone TEVA
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.